An emerging paradigm is that RIPK3 is a central mediator of lung tissue injury in murine models of acute lung injury (ALI), sepsis/systemic inflammatory associated organ injury, and chronic lung diseases [170,171,172]. Here, RIPK3 is linked to acute respiratory distress syndrome.